Appropriate use of recombinant factor VIIa: An expanding and unanswered question

Transfusion

Volumn 44, Issue 11, 2004, Pages 1544-1546

  Zimring, James C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BRAIN HEMORRHAGE; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; HUMAN; MEDICAL ASSESSMENT; REFERENCE VALUE; TREATMENT FAILURE;

ANTIBODIES; FACTOR VII DEFICIENCY; FACTOR VIIA; HEMORRHAGE; HUMANS; RECOMBINANT PROTEINS;

EID: 7244239502     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2004.44112.x     Document Type: Editorial

References (12)

1. Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev 2003;17(Suppl 1):S1-5.
2. Huang WY, Kruskall MS, Bauer KA, Uhl L, Shaz BH. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Transfusion 2004;44:000-0.
3. Mindikoglu AL, Anantharaju A, George M, et al. Acute intracranial hemorrhage in a cirrhotic controlled with recombinant factor VIIa. Digest Dis Sci 2003;48:1130-5.
4. Rice KM, Savidge GF. NovoSeven (recombinant factor VIIa) in central nervous systems bleeds. Haemostasis 1996;26(Suppl 1):131-4.
5. Arkin S, Cooper HA, Hutter JJ, et al. Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors: results of the NovoSeven emergency-use program. Haemostasis 1998;28:93-8.
6. Lusher J, Ingerslev J, Roberts H, Hedner U. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinolysls 1998;9:119-28.
7. Barber A, Green D, Galluzzo T, Ts'ao CH. The bleeding time as a preoperative screening test. Am J Med 1985;78:761-4.
8. De Caterina R, Lanza M, Manca G, et al. Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood 1994;84:3363-70.
9. Gewirtz AS, Miller ML, Keys TF. The clinical usefulness of the preoperative bleeding time. Arch Pathol Lab Med 1996;120:353-6.
10. Peterson P, Hayes TE, Arkin CF, et al. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998;133:134-9.
11. Mumtaz H, Williams V, Hauer-Jensen M, et al. Central venous catheter placement in patients with disorders of hemostasis. Am J Surg 2000;180:503-5; discussion 6.
12. Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy - a prospective audit. Intensive Care Med 1999;25:481-5.